Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany
Wolfgang Greiner(Bielefeld University), R. Sabatowski(University Hospital Carl Gustav Carus), Christoph Bug(Janssen (Germany)), Stephanie Earnshaw(RTI International), K. A. Lehmann(University of Cologne)
Cited by 29
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465